The role of complement in cryoglobulin-induced immune complex glomerulonephritis

Journal of Immunology

Volumn 175, Issue 10, 2005, Pages 6909-6914

  Trendelenburg, Marten ^a   Fossati Jimack, Liliane ^a   Cortes Hernandez, Josefina ^a   Turnberg, Daniel ^a   Lewis, Margarita ^a   Izui, Sliozo ^b   Cook, H Terence ^a   Botto, Marina ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTIBODY; CD59 ANTIGEN; CD59A ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; CRYOGLOBULIN; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CRYOGLOBULINEMIA; CRYOPRECIPITATE; GLOMERULONEPHRITIS; HYBRIDOMA; IMMUNE COMPLEX NEPHRITIS; INFLAMMATION; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

EID: 27744480228     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.10.6909     Document Type: Article

References (22)

1. Schifferli, J. A., and R. P. Taylor. 1989. Physiological and pathological aspects of circulating immune complexes. Kidney Int. 35: 993-1003.
2. Unanue, E., and F. J. Dixon. 1964. Experimental glomerulonephritis. IV. Participation of complement in nephrotoxic nephritis. J. Exp. Med. 119: 965-982.
3. Rofason, M. G., H. T. Cook, M. Botto, P. R. Taylor, N. Busso, R. Salvi, C. D. Pusey, M. J. Walport, and K. A. Davies. 2001. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J. Immunol. 166: 6820-6828.
4. Brouet, J. C., J. P. Clauvel, F. Danon, M. Klein, and M. Seligmann. 1974. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am. J. Med. 57: 775-788.
5. Gyotoku, Y., M. Abdelmoula, F. Spertini, S. Izui, and P. H. Lambert. 1987. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice. J. Immunol. 138: 3785-3792.
6. Lemoine, R., T. Berney, T. Shibata, T. Fulpius, Y. Gyotoku, H. Shimada, S. Sawada, and S. Izui. 1992. Induction of "wire-loop" lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int. 41: 65-72.
7. Churg, J. 1995. Renal Disease: Classification and Atlas of Glomerular Diseases. Igaku-Shoin, New York, Tokyo.
8. Reininger, L., T. Berney, T. Shibata, F. Spertini, R. Merino, and S. Izui. 1990. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc. Natl. Acad. Sci. USA 87: 10038-10042.
9. Fulpius, T., R. Lemoine, T. Berney, Y. Pastore, S. Moll, and S. Izui. 1996. Polymorphonuclear leukocytes play a key role in the generation of "wire-loop" lesions induced by a murine IgG3 rheumatoid factor. Kidney Int. 49: 647-655.
10. Watanabe, N., B. Akikusa, S. Y. Park, H. Ohno, L. Fossati, G. Vecchietti, J. E. Gessner, R. E. Schmidt, 3. S. Verbeek, B. Ryffel, et al. 1999. Mast cells induce autoantibody-mediated vasculitis syndrome through tumor necrosis factor production upon triggering Fc γ receptors. Blood 94: 3855-3863.
11. Izui, S., T. Fulpius, L. Reininger, Y. Pastore, and T. Kobayakawa. 1998. Role of neutrophils in murine Cryoglobulinemia. Inflamm. Res. 4(Suppl. 3): S145-S150.
12. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous Clq deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19: 56-59.
13. Fischer, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157: 549-556.
14. Wessels, M. R., P. Butko, M. Ma, H. B. Warren, A. L. Lage, and M. C. Carroll. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92: 11490-11494.
15. Berney, T., T. Fulpius, T. Shibata, L. Reininger, J. Van Snick, H. Shan, M. Weigert, A. Marshak-Rothstein, and S. Izui. 1992. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int. Immunol. 4: 93-99.
16. Mizuochi, T., Y. Pastore, K. Shikata, A. Kuroki, S. Kikuchi, T. Fulpius, M. Nakata, L. Fossati-Jimack, L. Reininger, M. Matsushita, et al. 2001. Role of galactosylation in the renal pathogenicity of murine immunoglobulin G3 monoclonal cryoglobulins. Blood 97: 3537-3543.
17. Kikuchi, S., Y. Pastore, L. Fossati-Jimack, A. Kuroki, H. Yoshida, T. Fulpius, K. Araki, S. Takahashi, R. Lemoine, L. Reininger, et al. 2002. A transgenic mouse model of autoimmune glomerulonephritis and necrotizing arteritis associated with cryoglobulinemia. J. Immunol. 169: 4644-4650.
18. Yu, J. X., B. M. Bradt, and N. R. Cooper. 2002. Constitutive expression of proinflammatory complement components by subsets of neurons in the central nervous system. J. Neuroimmunol 123: 91-101.
19. Adu, D., and D. G. Williams. 1984. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus. Clin. Exp. Immunol. 55: 495-501.
20. Muhlfeld, A. S., S. Segerer, K. Hudkins, A. G. Farr, L. Bao, D. Kraus, V. M. Holers, R. J. Quigg, and C. E. Alpers. 2004. Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis. Kidney Int. 65: 1214-1223.
21. Schifferli, J. A., G. Steiger, G. Hauptmann, P. J. Spaeth, and A. G. Sjoholm. 1985. Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states: difference between inhibition of immune precipitation and solubilization. J. Clin. Invest. 76: 2127-2133.
22. Fitch, J. C., S. Rollins, L. Matis, B. Alford, S. Aranki, C. D. Collard, M. Dewar, J. Elefteriades, R. Hines, G. Kopf, et al. 1999. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardio-pulmonary bypass. Circulation 100: 2499-2506.